Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Targeting insulin-like growth factor pathways
D. Yee
Medicine - Hematology, Oncology, Transplant
Research output
:
Contribution to journal
›
Short survey
›
peer-review
96
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeting insulin-like growth factor pathways'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Insulin-like
100%
Insulin-like Growth Factor 1 Receptor (IGF1R)
100%
Growth Factor Pathway
100%
Breast Cancer
50%
New Drugs
50%
Trastuzumab
50%
Cancer Therapy
50%
Cancer Cells
50%
Growth Potential
50%
Early Phase Clinical Trials
50%
Metastatic Potential
50%
Survival Chances
50%
Receptor System
50%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Somatomedin
100%
Clinical Trial
33%
Tamoxifen
33%
Breast Cancer
33%
Receptor
33%
Somatomedin C Receptor
33%
Metastasis Potential
33%
Trastuzumab
33%